Cargando…

Infections Deaths in the PLATO Trial

Background  Cardiovascular benefits of aggressive dual antiplatelet therapy may be associated with extra risks including bleeding, cancer, and infections discovered first for prasugrel in the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel (TRITON...

Descripción completa

Detalles Bibliográficos
Autores principales: Serebruany, Victor, Tanguay, Jean-Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575605/
https://www.ncbi.nlm.nih.gov/pubmed/34765866
http://dx.doi.org/10.1055/s-0041-1736638